A decreased level of PGC-1α has been reported in the cortex of AD patients, while exogenous expression of PGC-1α can significantly inhibit Aβ plaque formation by suppressing BACE1 transcription (Katsouri et al., 2011). This evidence concerns the gene BACE1 and Alzheimer disease.